Literature DB >> 21189070

Chondrogenesis of rabbit mesenchymal stem cells in fibrin/hyaluronan composite scaffold in vitro.

Sang-Hyug Park1, Byung Hyune Choi, So Ra Park, Byoung-Hyun Min.   

Abstract

Scaffold material is expected to play a crucial role in induction of chondrogenic differentiation of mesenchymal stem cells (MSCs) for cartilage tissue engineering. Here we demonstrated the feasibility of a fibrin/hyaluronan (HA) composite hydrogel as a potent scaffold for support of chondrogenesis of rabbit MSCs (rMSCs). rMSCs were prepared in three-dimensional cultures of pellet, alginate layer, and fibrin/HA gel. Specimens in each group were cultured in chondrogenic defined media for 4 weeks in the absence or presence of transforming growth factor β1 (TGF-β1) treatment. Viability of rMSCs was somewhat reduced until 4 weeks, which was less significant in fibrin/HA gels than in the alginate layer (*p < 0.05). The fibrin/HA group showed transient size reduction by about 35% at 1 week, but showed significantly higher mechanical strength than the alginate group. In safranin-O and alcian blue stains, accumulation of sulfated glycosaminoglycans (GAGs) was observed clearly from 1 week, and homogenously in the entire area at 4 weeks in the fibrin/HA group. Of note, TGF-β1 treatment showed no additional effect on GAGs accumulation in the fibrin/HA group. The alginate and pellet groups, however, showed much lower levels of GAGs accumulation only in the presence of TGF-β1. Biochemical assays for GAGs and collagen, and expression of chondrogenic markers also showed much better results in the fibrin/HA group, even without TGF-β treatment than the other groups. These results demonstrated that fibrin/HA composite gel efficiently promoted chondrogenic differentiation of rMSCs, even without TGF-β treatment, and that it could be a useful tool for use in cartilage tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21189070     DOI: 10.1089/ten.TEA.2010.0337

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  7 in total

Review 1.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine.

Authors:  Amanda N Renth; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2012-05-21       Impact factor: 6.389

2.  Tissue-engineered artificial oesophagus patch using three-dimensionally printed polycaprolactone with mesenchymal stem cells: a preliminary report.

Authors:  Seong Yong Park; Jae Won Choi; Ju-Kyeong Park; Eun Hye Song; Su A Park; Yeon Soo Kim; Yoo Seob Shin; Chul-Ho Kim
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-10

Review 3.  Functionality of decellularized matrix in cartilage regeneration: A comparison of tissue versus cell sources.

Authors:  Yu Sun; Lianqi Yan; Song Chen; Ming Pei
Journal:  Acta Biomater       Date:  2018-04-24       Impact factor: 8.947

4.  Combined effect of subchondral drilling and hyaluronic acid with/without diacerein in full-thickness articular cartilage lesion in rabbits.

Authors:  Wanwisa Suwannaloet; Wiroon Laupattarakasem; Peerapol Sukon; Siriwan Ong-Chai; Pisamai Laupattarakasem
Journal:  ScientificWorldJournal       Date:  2012-04-30

5.  Rheological and biological properties of a hydrogel support for cells intended for intervertebral disc repair.

Authors:  Karin Benz; Claudia Stippich; Claudia Osswald; Christoph Gaissmaier; Nicolas Lembert; Andreas Badke; Eric Steck; Wilhelm K Aicher; Juergen A Mollenhauer
Journal:  BMC Musculoskelet Disord       Date:  2012-04-10       Impact factor: 2.362

6.  A fibrin/hyaluronic acid hydrogel for the delivery of mesenchymal stem cells and potential for articular cartilage repair.

Authors:  Timothy N Snyder; Krishna Madhavan; Miranda Intrator; Ryan C Dregalla; Daewon Park
Journal:  J Biol Eng       Date:  2014-05-01       Impact factor: 4.355

Review 7.  Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications.

Authors:  Thanavel Rajangam; Seong Soo A An
Journal:  Int J Nanomedicine       Date:  2013-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.